|
12 Jun 2007 |
Coley Pharmaceutical Group Broadens Leading Toll-like Receptor (TLR) Platform Through Strategic Acquisition of 3M Company's TLR Therapeutic Research and Development Programs
|
|
09 Jun 2007 |
Mylan Announces Final FDA Approval for Doxycycline Tablets, 150mg
|
|
08 Jun 2007 |
Alkermes Announces Initiation of Phase I Clinical Study of AIR(R) Parathyroid Hormone
|
|
08 Jun 2007 |
BioMimetic Therapeutics Initiates Enrollment in E.U. Registration Trial for GEM OS(R)1 Bone Graft; U.S. GEM OS1 Pivotal Study Protocol Amended to Allow Shorter Follow-Up Time and More Patients
|
|
08 Jun 2007 |
BioMimetic Therapeutics Initiates Enrollment in E.U. Registration Trial for GEM OS(R)1 Bone Graft; U.S. GEM OS1 Pivotal Study Protocol Amended to Allow Shorter Follow-Up Time and More Patients
|
|
08 Jun 2007 |
Genzyme to Build New Biomanufacturing Plant to Support Growth of Thymoglobulin(R)
|
|
07 Jun 2007 |
Amgen to Acquire Alantos Pharmaceuticals, a Private Biotechnology Company in Cambridge, Massachusetts
|
|
07 Jun 2007 |
Abbott and Caprion Extend Partnership to Discover Antibody Targets for Cancer
|
|
06 Jun 2007 |
Inovio Biomedical Stops Enrollment of Phase III Clinical Trials for Head & Neck Cancer
|
|
06 Jun 2007 |
Unigene Reports That Oral Calcitonin Phase III Clinical Study for Osteoarthritis Treatment is Initiated
|
|
05 Jun 2007 |
Amgen to Acquire Ilypsa, a Private San Francisco Bay Area Biotechnology Company Focused on Kidney Disease Care
|
|
03 Jun 2007 |
ABRAXANE Demonstrates Longer Progression-Free Survival versus Taxotere in the Treatment of First-Line Metastatic Breast Cancer
|
|
02 Jun 2007 |
Indigo Pharmaceuticals, Inc. Signs License Agreement for INDI-702, a Drug for the Treatment of Arteriosclerosis Obliterans, With Nissan Chemical Industries and Taisho Pharmaceutical Co.
|
|
02 Jun 2007 |
Arrowhead subsidiary, Insert, publishes interim Phase I data from human clinical trials for new cancer drug
|
|
02 Jun 2007 |
Abbott Submits XIENCE(TM) V Everolimus Eluting Coronary Stent System Application for U.S. FDA Approval
|
|
01 Jun 2007 |
Indevus Announces Authorization for Approval of VANTAS(R) in Selected European Countries
|
|
01 Jun 2007 |
Wockhardt gets US FDA nod to enter the $680 million Lamisil market
|
|
01 Jun 2007 |
Medarex Announces Collaborative Research Agreement with Mitsubishi Pharma
|
|
01 Jun 2007 |
Skyepharma PLC - Twice daily ZYFLO CR(TM) (zileuton) extended-release tablets approved by the FDA for asthma
|
|
01 Jun 2007 |
Northstar Neuroscience Announces the Completion of Subject Enrollment and Randomization in the EVEREST Pivotal Trial for Upper Extremity Motor Recovery in Stroke Survivors
|
|
01 Jun 2007 |
Mylan Announces Final FDA Approval for Azithromycin Tablets
|
|
01 Jun 2007 |
Mylan Announces Tentative FDA Approval for Paroxetine Hydrochloride Extended-Release Tablets
|
|
01 Jun 2007 |
ProBioGen and Virbac signed a Licensing Agreement to use ProBioGen’s Novel Avian Cell Line AGE1 for Production of Biological Products
|
|
01 Jun 2007 |
Advanced Cell Technology Enters Into Letter of Intent to Acquire Mytogen, Inc. and Proceed with the Human Clinical Trials Utilizing Myoblasts for the Treatment of Heart Failure
|
|
01 Jun 2007 |
MIV Therapeutics Announces Start of Clinical Trial Marking First Ever Human Implantation of A Hydroxyapatite Coated Stent
|
